Marshall Wace
APGE icon

Marshall Wace’s Apogee Therapeutics APGE Stock Holding History

Marshall Wace’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75M Buy
80,201
+29,457
+58% +$2.14M 0.01% 1155
2025
Q4 		$3.83M Buy
50,744
+43,717
+622% +$2.75M ﹤0.01% 1273
2025
Q3 		$279K Sell
7,027
-83,541
-92% -$3.19M ﹤0.01% 2457
2025
Q2 		$3.93M Buy
90,568
+78,969
+681% +$3M ﹤0.01% 1266
2025
Q1 		$433K Sell
11,599
-64,250
-85% -$2.48M ﹤0.01% 2134
2024
Q4 		$3.44M Buy
75,849
+72,174
+1,964% +$3.68M ﹤0.01% 1229
2024
Q3 		$216K Sell
3,675
-78,271
-96% -$3.75M ﹤0.01% 2274
2024
Q2 		$3.22M Buy
+81,946
New +$3.98M ﹤0.01% 1168

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return